Atrial septal defect percutaneous closure benefits: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Benefits of percutaneous closure== | ==Benefits of percutaneous closure== | ||
The | The percutaneous closure of [[Atrial septal defect ostium secundum|ostium secundum]] is the method of choice in many centers.<ref>{{cite journal | author = Bjørnstad P | title = Is interventional closure the current treatment of choice for selected patients with deficient atrial septation? | journal = Cardiol Young | volume = 16 | issue = 1 | pages = 3-10 | year = 2006 | id = PMID 16454871}}</ref><ref name="pmid10525508">{{cite journal| author=Dhillon R, Thanopoulos B, Tsaousis G, Triposkiadis F, Kyriakidis M, Redington A| title=Transcatheter closure of atrial septal defects in adults with the Amplatzer septal occluder. | journal=Heart | year= 1999 | volume= 82 | issue= 5 | pages= 559-62 | pmid=10525508 | doi= | pmc=PMC1760778 | url= }} </ref>. The benefits that can be associated with the closure are as follow: | ||
====Disease Related Benefits==== | |||
====Disease | |||
*Fewer complications compared to [[Atrial septal defect surgical closure | surgical closure]] | *Fewer complications compared to [[Atrial septal defect surgical closure | surgical closure]] | ||
| Line 19: | Line 18: | ||
**Improved peak oxygen uptake | **Improved peak oxygen uptake | ||
====Other | ====Other Benefits==== | ||
* Less invasive no need for [[cardiopulmonary bypass]] | * Less invasive no need for [[cardiopulmonary bypass]] | ||
Revision as of 19:16, 9 January 2013
|
Atrial Septal Defect Microchapters | |
|
Treatment | |
|---|---|
|
Surgery | |
|
| |
|
Special Scenarios | |
|
Case Studies | |
|
Atrial septal defect percutaneous closure benefits On the Web | |
|
American Roentgen Ray Society Images of Atrial septal defect percutaneous closure benefits | |
|
Atrial septal defect percutaneous closure benefits in the news | |
|
Risk calculators and risk factors for Atrial septal defect percutaneous closure benefits | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3] Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [4]
Overview
Benefits of percutaneous closure
The percutaneous closure of ostium secundum is the method of choice in many centers.[1][2]. The benefits that can be associated with the closure are as follow:
Disease Related Benefits
- Fewer complications compared to surgical closure
- Reduced need for blood transfusions
- Symptomatic improvement
- Regression of positive airway pressure
- Positive changes in right ventricle performance
- Improved functional capacity [3]
- Improved left atrial volume index
- Improved left ventricular myocardial performance index
- Improved right ventricular myocardial performance index
- Improved peak oxygen uptake
Other Benefits
- Less invasive no need for cardiopulmonary bypass
- Successful implantation rates of more than 96%.
- Established practice (done in most hospital these days)
- Cost-effective
- Shorter hospital stays
References
- ↑ Bjørnstad P (2006). "Is interventional closure the current treatment of choice for selected patients with deficient atrial septation?". Cardiol Young. 16 (1): 3–10. PMID 16454871.
- ↑ Dhillon R, Thanopoulos B, Tsaousis G, Triposkiadis F, Kyriakidis M, Redington A (1999). "Transcatheter closure of atrial septal defects in adults with the Amplatzer septal occluder". Heart. 82 (5): 559–62. PMC 1760778. PMID 10525508.
- ↑ Salehian O, Horlick E, Schwerzmann M, Haberer K, McLaughlin P, Siu SC; et al. (2005). "Improvements in cardiac form and function after transcatheter closure of secundum atrial septal defects". J Am Coll Cardiol. 45 (4): 499–504. doi:10.1016/j.jacc.2004.10.052. PMID 15708694.